Art Therapy in Acute Schizophrenia
KUSS
Art Therapy for Symptom Reduction in Acute Schizophrenia - a Randomised Controlled Trial (Kunsttherapie Zur Symptomreduktion Bei Akuter Schizophrenie - Eine Randomisierte Kontrollierte Pilotstudie)
1 other identifier
interventional
60
1 country
1
Brief Summary
Randomised, controlled, single-blinded pilot study to assess the efficacy of psychodynamic art therapy in a sample of hospitalized, (sub)acutely psychotic patients with a diagnosis of schizophrenia compared to a group of patients receiving treatment as usual. \*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU. \*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Aug 2011
Shorter than P25 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 12, 2012
CompletedFirst Posted
Study publicly available on registry
June 19, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedOctober 24, 2014
October 1, 2014
1.4 years
June 12, 2012
October 22, 2014
Conditions
Outcome Measures
Primary Outcomes (3)
Change in Positive and Negative Syndrome Scale (PANSS-) scores
assessment of change of schizophrenic positive, negative and general symptom scores
weeks 0, 6, 12
safety measures
number of participants with adverse events
weeks 0, 6, 12
Change in Calgary depression Scale (CDS-) scores
assessment of change of depressive symptoms in schizophrenic patients as reflected by CDS-scores
weeks 0, 6, 12
Study Arms (2)
art therapy
EXPERIMENTAL12 sessions of art therapy / 6 weeks
TAU
NO INTERVENTIONtreatment as usual / 6 weeks
Interventions
2 sessions à 1.5 hrs /week, intervention duration 6 weeks
Eligibility Criteria
You may qualify if:
- diagnosis of schizophrenia according to DSM-IV-TR
- age 18-64 yrs
- sufficient German language competency
- written informed consent
You may not qualify if:
- axis-I mental disorders other than schizophrenia
- comorbid antisocial personality disorder, relevant substance abuse,
- relevant severe somatic disease
- acute suicidal tendencies or aggression
- incapability to tolerate group settings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Psychiatrische Universitätsklinik der Charité im St. Hedwig Krankenhaus
Berlin, 10115, Germany
Related Publications (1)
Montag C, Haase L, Seidel D, Bayerl M, Gallinat J, Herrmann U, Dannecker K. A pilot RCT of psychodynamic group art therapy for patients in acute psychotic episodes: feasibility, impact on symptoms and mentalising capacity. PLoS One. 2014 Nov 13;9(11):e112348. doi: 10.1371/journal.pone.0112348. eCollection 2014.
PMID: 25393414DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christiane Montag, M.D.
Charite University, Berlin, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 12, 2012
First Posted
June 19, 2012
Study Start
August 1, 2011
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
October 24, 2014
Record last verified: 2014-10